Professional Documents
Culture Documents
Fda 2010 N 0274 0029.1
Fda 2010 N 0274 0029.1
, DABCC
Executive Vice President Associate Professor, Pathology and Laboratory Medicine, University of Louisville School of Medicine
Compliance with CLIA (e.g. Subpart K) Guidance Documents (e.g. CAP, AMP) Maximize effectiveness of existing law and practices.
Representation of Laboratory Medical Directors Not to exceed current norms Focus on protecting interests of patients Reconcile, consolidate and clarify regulatory authority Avoid disruption of current qualified activities